Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity. Ramirez MA, Loaiza RA, Martinez-Balboa Y, Bruneau N, et al. Vaccine 2024;42:126203.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ramirez MA, Loaiza RA, Martinez-Balboa Y, Bruneau N, et al. Co-administration of recombinant BCG and SARS-CoV-2 proteins leads to robust antiviral immunity. Vaccine 2024;42:126203.
PMID: 39178767